Jessica K Altman

  • 4702 Citations
20052024

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Medical Oncology
Hematology
Internal Medicine

Training Experience

2004Residency, University of Chicago Hospitals
2007Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Pittsburgh

… → 2001

Research interests

  • Acute Leukemias
  • Anemia
  • Aplastic Anemia
  • Chronic Leukemias
  • Leukemia
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Targeted Therapies

Fingerprint Dive into the research topics where Jessica K Altman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

Unique morphologic and genetic characteristics of acute myeloid leukemia with chromothripsis: a clinicopathologic study from a single institution

Gao, J., Chen, Y. H., Mina, A., Altman, J. K., Kim, K. Y., Zhang, Y., Lu, X., Jennings, L. & Sukhanova, M., Apr 2020, In : Human pathology. 98, p. 22-31 10 p.

Research output: Contribution to journalArticle

  • Acute myeloid leukemia, version 3.2019

    Tallman, M. S., Wang, E. S., Altman, J. K., Appelbaum, F. R., Bhatt, V. R., Bixby, D., Coutre, S. E., De Lima, M., Fathi, A. T., Fiorella, M., Foran, J. M., Hall, A. C., Jacoby, M., Lancet, J., LeBlanc, T. W., Mannis, G., Marcucci, G., Martin, M. G., Mims, A., O'Donnell, M. R. & 14 others, Olin, R., Peker, D., Perl, A., Pollyea, D. A., Pratz, K., Prebet, T., Ravandi, F., Shami, P. J., Stone, R. M., Strickland, S. A., Wieduwilt, M., Gregory, K. M., Hammond, L. & Ogba, N., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 6, p. 721-749 29 p.

    Research output: Contribution to journalArticle

  • 24 Scopus citations
  • 2 Scopus citations

    A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease

    Litzow, M. R., Wang, X. V., Carroll, M. P., Karp, J. E., Ketterling, R. P., Zhang, Y., Kaufmann, S. H., Lazarus, H. M., Luger, S. M., Paietta, E. M., Pratz, K. W., Tun, H. W., Altman, J. K., Broun, E. R., Rybka, W. B., Rowe, J. M. & Tallman, M. S., Jan 2019, In : American Journal of Hematology. 94, 1, p. 111-117 7 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: A phase I trial

    Gangat, N., Marinaccio, C., Swords, R., Watts, J. M., Gurbuxani, S., Rademaker, A., Fought, A. J., Frankfurt, O., Altman, J. K., Wen, Q. J., Farnoud, N., Famulare, C. A., Patel, A., Tapia, R., Vallapureddy, R. R., Barath, S., Graf, A., Handlogten, A., Zblewski, D., Patnaik, M. M. & 14 others, Al-Kali, A., Dinh, Y. T., Prahl, K. E., Patel, S., Nobrega, J. C., Tejera, D., Thomassen, A., Gao, J., Ji, P., Rampal, R. K., Giles, F. J., Tefferi, A., Stein, B. & Crispino, J. D., Aug 15 2019, In : Clinical Cancer Research. 25, 16, p. 4898-4906 9 p.

    Research output: Contribution to journalArticle

  • 10 Scopus citations